ESPark Intervention for Parkinson's (NCT05433441)
Improve daily functioning through teams
- Trial ID
- NCT05433441
- Official Title
- Evaluation of the Effectiveness of the Parkinson's Specialized Teams Intervention on the Quality of Life of Parkinson's Patients in the Territory of the Nouvelle-Aquitaine and Hauts-de-France: ES-Park Pilot Study.
- Goal
- Improve daily functioning through teams
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- University Hospital, Bordeaux
- Study Type
- INTERVENTIONAL
- Enrollment
- 250 participants
- Conditions
- Parkinson Disease
- Interventions
- ESPark Intervention
Summary For Families
The trial is testing whether specialized, multidisciplinary Parkinson's teams can improve quality of life for people with more advanced Parkinson's in the Nouvelle-Aquitaine and Hauts-de-France regions. The teams deliver coordinated, individualized care such as medication review, tailored physical and occupational therapy plans, home-based support and caregiver education, aiming to reduce disability, falls and daily burden rather than testing a drug. They are enrolling adults with idiopathic Parkinson's who are Hoehn and Yahr stage 3 or higher, have no major cognitive impairment (MOCA ≥21), live at home and have a willing nonprofessional caregiver. Both patient and caregiver must consent and be able to complete follow-up interviews, while people with dementia, imminent institutionalization, severe unstable illness or participation in other non-drug management trials are excluded.
Locations
- Hopital Pellegrin, Bordeaux, France
- CHU de Lille, Lille, France
- CHU de Limoges, Limoges, France
- CHU Poitiers, Poitiers, France
Frequently Asked Questions
- What is this trial testing?
- This trial is studying ESPark Intervention. The trial is testing whether specialized, multidisciplinary Parkinson's teams can improve quality of life for people with more advanced Parkinson's in the Nouvelle-Aquitaine and Hauts-de-France regions. The teams deliver coordinated, individualized care such as medication review, tailored physical and occupational therapy plans, home-based support and caregiver education, aiming to reduce disability, falls and daily burden rather than testing a drug. They are enrolling adults with idiopathic Parkinson's who are Hoehn and Yahr stage 3 or higher, have no major cognitive impairment (MOCA ≥21), live at home and have a willing nonprofessional caregiver. Both patient and caregiver must consent and be able to complete follow-up interviews, while people with dementia, imminent institutionalization, severe unstable illness or participation in other non-drug management trials are excluded.
- Who can participate?
- Participants must be at least 18 Years.
- Where is this trial located?
- This trial is recruiting at 4 locations.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 3 years.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This is a crossover trial: instead of staying in one group, you move through a sequence of assignments, so you receive the active treatment during at least one period of the study. Ask the coordinator for the exact sequence and how long each phase lasts.